- Home
- FLYE vs ITOC Comparison
FLYE vs ITOC Comparison
Compare FLYE & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLYE | ITOC |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Aerospace | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 7.0M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | FLYE | ITOC |
|---|---|---|
| Price | $1.94 | $0.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.0K | ★ 28.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,427,163.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.33 | $0.31 |
| 52 Week High | $21.80 | $0.65 |
Technical Indicators
Market Signals| Indicator | FLYE | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 28.37 | 29.38 |
| Support Level | $1.80 | N/A |
| Resistance Level | $5.87 | $0.38 |
| Average True Range (ATR) | 0.16 | 0.03 |
| MACD | 0.14 | 0.00 |
| Stochastic Oscillator | 21.23 | 25.80 |
Price Performance
Historical ComparisonAbout FLYE Fly-E Group Inc.
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.
About ITOC iTonic Holdings Ltd Class A Ordinary Shares
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.